The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Apr. 07, 2016
Applicant:

Acist Medical Systems, Inc., Eden Prairie, MN (US);

Inventor:

Jason F. Hiltner, Minnetonka, MN (US);

Assignee:

ACIST MEDICAL SYSTEMS, INC., Eden Prairie, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/0215 (2006.01); A61B 5/026 (2006.01); A61M 5/168 (2006.01); A61M 25/06 (2006.01); A61M 25/09 (2006.01); A61B 5/02 (2006.01); A61M 25/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/6876 (2013.01); A61B 5/0022 (2013.01); A61B 5/026 (2013.01); A61B 5/02158 (2013.01); A61B 5/68 (2013.01); A61B 5/7278 (2013.01); A61M 5/168 (2013.01); A61M 25/0662 (2013.01); A61M 25/09 (2013.01); A61B 5/02 (2013.01); A61M 2025/0057 (2013.01); A61M 2025/09133 (2013.01);
Abstract

Methods, systems, and devices are disclosed for administering one or more medications useful for facilitating diagnostic and/or surgical procedures within a patient. A guidewire is positioned intravascularly in a patient at a location of interest, the guidewire being free of any coating that includes adenosine. An intravascular component having a surface with a coating that includes a vasodilation agent is deployed over the guidewire. The vasodilation agent is released from the surface of the intravascular component, such as by eluting the vasodilation agent from the coating of the surface while the intravascular component is within the anatomical structure of the patient. The intravascular component is removed over the guidewire, and the guidewire is left at the location of interest after the intravascular component is removed, which can facilitate subsequent deployment of a different intravascular component over the guidewire.


Find Patent Forward Citations

Loading…